SLC16A1 and cardiac hypertrophy: A recent study in cardiac hypertrophy reported SIRT3-dependent enhancement of ketone body metabolism via AMPK-mediated increase in the levels of monocarboxylic transporters 1 (MCT1) and 3-oxoacid CoA-transferase (OXCT1) (60).